PATENT CLAIM ANALYSIS

Application Number: 15759203
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "009400"]

Abstract:
This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.

Claim (Index 6):
The method of  claim 1 , wherein the composition acts to inhibit \u03b1-smooth muscle actin (\u03b1-SMA) in the cornea.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12685510', '13549770', '14071559', '10133234', '14821567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7548470706890485
- 35 USC 102 Novelty (BERT): 0.5335439862224736
- Combined Prediction Score: 0.732716762242391
- Mean Citation Score: 295.559032
- Max Citation Score: 328.05212
- Similarity Product: 213.2191659992075

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test